Comparative Study of Different Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors Affecting Lung Cancer Cell Lines Stably Overexpressing EGFR Mutations

Authors :: Toshihiro Ishii
Yuichiro Kanno
Kiyomitsu Nemoto
Tomohiro Ariyama
Sonomi Takizawa
Source :: BPB Reports. 4:12-16
Publication Year :: 2021
Publisher :: Pharmaceutical Society of Japan, 2021.

Subjects :: Lung cancer cell
biology
Egfr mutation
business.industry
Cancer research
biology.protein
Medicine
Epidermal growth factor receptor
General Agricultural and Biological Sciences
business
EGFR Tyrosine Kinase Inhibitors

Full Text Access

Tools